Andrew Obenshain
Chief Executive Officer bij BLUEBIRD BIO, INC.
Vermogen: 358 397 $ op 31-03-2024
Profiel
Andrew Obenshain is currently the President, Chief Executive Officer & Director at bluebird bio, Inc. since 2021.
He is also currently serving as a Director at bluebird bio (UK) Ltd.
since 2017.
Previously, he worked as the General Manager-Finance at Shire France SAS.
Mr. Obenshain completed his undergraduate degree at Dartmouth College and holds an MBA from Kellogg School of Management.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BLUEBIRD BIO, INC.
0.15% | 04-03-2024 | 279 998 ( 0.15% ) | 358 397 $ | 31-03-2024 |
Actieve functies van Andrew Obenshain
| Bedrijven | Functie | Begin |
|---|---|---|
| BLUEBIRD BIO, INC. | Chief Executive Officer | 04-11-2021 |
bluebird bio (UK) Ltd.
 bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The private company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Director/Board Member | 30-03-2017 |
Eerdere bekende functies van Andrew Obenshain
| Bedrijven | Functie | Einde |
|---|---|---|
Shire France SAS
 Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Opleiding van Andrew Obenshain
| Dartmouth College | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The private company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Health Technology |
